Changing stroke rehab and research worldwide now.Time is Brain! trillions and trillions of neurons that DIE each day because there are NO effective hyperacute therapies besides tPA(only 12% effective). I have 523 posts on hyperacute therapy, enough for researchers to spend decades proving them out. These are my personal ideas and blog on stroke rehabilitation and stroke research. Do not attempt any of these without checking with your medical provider. Unless you join me in agitating, when you need these therapies they won't be there.

What this blog is for:

My blog is not to help survivors recover, it is to have the 10 million yearly stroke survivors light fires underneath their doctors, stroke hospitals and stroke researchers to get stroke solved. 100% recovery. The stroke medical world is completely failing at that goal, they don't even have it as a goal. Shortly after getting out of the hospital and getting NO information on the process or protocols of stroke rehabilitation and recovery I started searching on the internet and found that no other survivor received useful information. This is an attempt to cover all stroke rehabilitation information that should be readily available to survivors so they can talk with informed knowledge to their medical staff. It lays out what needs to be done to get stroke survivors closer to 100% recovery. It's quite disgusting that this information is not available from every stroke association and doctors group.

Friday, March 4, 2011

New Zealand stroke research

http://www.nzherald.co.nz/health/news/article.cfm?c_id=204&objectid=10685204
http://tvnz.co.nz/health-news/high-hopes-stroke-research-breakthrough-3877861
http://www.nzdoctor.co.nz/un-doctored/2010/november-2010/04/otago-research-uncovers-potential-for-stroke-victims-to-dramatically-regain-mobility-.aspx
None of the links I tried specified what drug was being tested. I will be going to the library to see if the Nature article mentions it. I like the possible 3 week window.

University of Otago and American researchers have discovered a drug therapy which could dramatically help stroke victims by unlocking paralysed arms and legs and restoring much of their lost mobility.
Results of the 2 year study were published today in the online edition of the international scientific journal Nature.
"This also provides hope for those with traumatic head injuries - the brain mechanisms of repair are similar so there is potential for this to work for them too," study co-author Dr Andrew Clarkson said.
Dr Clarkson, 31, a research fellow at the Otago University departments of psychology and anatomy and structural biology, said human trials using the drug compounds could begin within two years.
One compound, known to enhance cognition and initially developed to treat Alzheimer's disease, is already being tested in people with learning difficulties.
In the first study of its kind, Dr Clarkson and colleagues at the University of California, including neurologist co-author Dr Thomas Carmichael, found the compound, given to mice in slow-release doses, re-activated brain neurons responsible for limb function.
Six weeks of treatment produced dramatic results, with an extra 50 per cent of gross motor limb mobility consistently gained. Treatment of the mice began three days after the stroke - the equivalent of about three weeks in humans.
Dr Clarkson said the finding was "tremendous" and could be "the biggest therapeutic breakthrough in many years".
The treatment worked on gross motor skills, but it would take further research to clarify whether the drug could also help with the fine motor skills associated with speech.
The research suggests some brain cells affected by strokes or other head injuries have not been killed, as often previously thought, but are effectively "sleeping" and can be reactivated.

Ok, a couple of lines from the article:
This increased tonic inhibition is mediated by extrasynaptic GABAA receptors and is caused by an impairment in GABA (γ-aminobutyric acid) transporter (GAT-3/GAT-4) function. To counteract the heightened inhibition, we administered in vivo a benzodiazepine inverse agonist specific for α5-subunit-containing extrasynaptic GABAA receptors at a delay after stroke. This treatment produced an early and sustained recovery of motor function.
What!!

No comments:

Post a Comment